FN2 Earnings Intelligence
Texas Instruments Incorporated financials
Texas Instruments Incorporated (TXN) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $4,631 | $3,050 | $2,964 | $3,200 | $3,225 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $18,344 | $20,028 | $17,519 | $15,641 | $17,682 | $21,939.1 | $24,976.5 |
| % Growth | 26.9% | 9.2% | -12.5% | -10.7% | 13.0% | 24.1% | 13.8% |
| Gross Profit | $12,376 | $13,771 | $11,019 | $9,094 | $10,083 | - | - |
| % Margin | 67.5% | 68.8% | 62.9% | 58.1% | 57.0% | - | - |
| EBITDA | $9,715 | $11,065 | $8,506 | $6,973 | $7,941 | - | - |
| % Margin | 53.0% | 55.2% | 48.6% | 44.6% | 44.9% | - | - |
| Net Income | $7,769 | $8,749 | $6,510 | $4,799 | $5,001 | - | - |
| % Margin | 42.4% | 43.7% | 37.2% | 30.7% | 28.3% | - | - |
| Diluted EPS | $8.26 | $9.41 | $7.07 | $5.20 | $5.45 | $8.51 | $10.27 |
| % Growth | 38.4% | 13.9% | -24.9% | -26.4% | 4.8% | 56.2% | 20.7% |
| Operating Cash Flow | $8,756 | $8,720 | $6,420 | $6,318 | $7,153 | - | - |
| CapEx | $2,462 | $2,797 | $5,071 | $4,820 | $4,550 | - | - |
| Free Cash Flow | $6,294 | $5,923 | $1,349 | $1,498 | $2,603 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $18,344 | $20,028 | $17,519 | $15,641 | $17,682 | $21,939.1 | $24,976.5 |
| Gross Profit | $12,376 | $13,771 | $11,019 | $9,094 | $10,083 | - | - |
| EBITDA | $9,715 | $11,065 | $8,506 | $6,973 | $7,941 | - | - |
| Net Income | $7,769 | $8,749 | $6,510 | $4,799 | $5,001 | - | - |
| Diluted EPS | $8.26 | $9.41 | $7.07 | $5.20 | $5.45 | $8.51 | $10.27 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $4,631 | $3,050 | $2,964 | $3,200 | $3,225 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $7,241 | $8,235 | $10,624 | $12,846 | $13,548 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $8,756 | $8,720 | $6,420 | $6,318 | $7,153 |
| Capital Expenditure | $2,462 | $2,797 | $5,071 | $4,820 | $4,550 |
| Free Cash Flow | $6,294 | $5,923 | $1,349 | $1,498 | $2,603 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 26.9% | 9.2% | -12.5% | -10.7% | 13.0% |
| Gross Margin | 67.5% | 68.8% | 62.9% | 58.1% | 57.0% |
| EBITDA Margin | 53.0% | 55.2% | 48.6% | 44.6% | 44.9% |
| Net Margin | 42.4% | 43.7% | 37.2% | 30.7% | 28.3% |
| FCF Margin | 34.3% | 29.6% | 7.7% | 9.6% | 14.7% |
| Diluted EPS Growth | 38.4% | 13.9% | -24.9% | -26.4% | 4.8% |